Gilles Degotte, PhD
degottegilles.bsky.social
Gilles Degotte, PhD
@degottegilles.bsky.social
Postdoc in medicinal chemistry at University California San Francisco, covalent drugs/ natural products/ infectious diseases
#chemistry

When your compound is crystallizing overnight to form a huge nice looking gemstone 💎

#medchem
February 15, 2025 at 7:03 PM
👨‍🔬 #Jobhunting

I recently added the #opentowork to my profile. My time at UCSF, with Prof. Renslo is ending soon.

Therefore, I am looking for my next challenge 🔬

Don't hesitate to share any position you may come across ⚗️

Thank you in advance✨

#medchem #chembio #career
January 14, 2025 at 4:08 AM
Reposted by Gilles Degotte, PhD
Don't miss the EFMC Short Course on "AI and Medicinal Chemistry: Innovations and Challenges" in Oegstgeest, Netherlands, April 6–9, 2025.

Explore AI's role, new advancements, and tools with industry experts. Only 35 spots available.

Apply for EFMC grants by Jan 10

🔗 https://buff.ly/3ZReJTe
December 13, 2024 at 10:00 AM
Reposted by Gilles Degotte, PhD
💙 We've officially moved to Bluesky! 💙

While we’ve loved connecting with you on X/Twitter, it's time for a fresh start in a platform that aligns with our values & vision.

Join the conversation & stay updated with all things EFMC. Let’s build an inclusive and sustainable community together.
December 3, 2024 at 3:08 PM
Excited to see that our last paper is available from my collaboration with Professor Josef Jampilek (Palacký University Olomouc) and the University of Liège!

Congratulations to the team!

Check it out ➡️ www.sciencedirect.com/science/arti...
Trifluoromethylcinnamanilides – Effective dual inhibitors of Mycobacterium smegmatis and Plasmodium falciparum
A series of eighteen new 2-trifluoromethylcinnamanilides (1a–r) were synthesized by microwave synthesis and investigated for their antimycobacterial a…
www.sciencedirect.com
December 13, 2024 at 5:53 PM